M. Jaione Maiz
Investor | Business Development | Kauffman Fellow
Redwood City, California
Overview
Work Experience
Principal, Venture Capital
2021 - 2024
Anzu Partners is an investment firm that focuses on breakthrough industrial and life sciences technology companies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. https://www.anzupartners.com/
Anzu Partners is an investment firm that invests in industrial and life science technology companies.
Board Observer
2023 - 2024
Renegade.bio provides rapid and cost-effective diagnostic testing for detection of novel infectious diseases.
Raised $1,134,000.00 from SOSV.
Board Observer
2023 - 2024
Codetta Bio is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.
Raised $29,280,996.00 from Collaboratory.
Board Observer
2022 - 2024
Board Observer
2022 - 2024
Interim Chief Business Officer
2022 - 2023
Active portfolio company support is an important part of our investor mandate at Anzu Partners. I had the opportunity to work deeply with our company NTx to lead the company’s commercial transformation including go-to-market strategy, commercial operations, and key partnerships. — Nature's Toolbox, Inc. (NTx) is a next-generation biomanufacturing company located in Rio Rancho, New Mexico. NTx's proprietary cell-free, continuous-flow, fully recombinant, in vitro systems utilize hollow fiber bioreactors to effectively and cost-efficiently produce biologics, including mRNA and proteins, to support the growing demand for next generation vaccines and therapeutics. NTx’s biomanufacturing solutions easily scale to meet fluctuating demand, and can operate using NTx's proprietary critical raw materials (including enzymes), to avoid fragile supply chain constraints in times of high market need. For more information, please visit: https://www.ntxbio.com
Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.
Raised $75,839,000.00 from JP Morgan.
Board Observer
2021 - 2024
Interim Chief Business Officer
2022 - 2022
Active portfolio company support is an important part of our investor mandate at Anzu Partners. I had the opportunity to work deeply with our company BioSkryb to lead the commercial team during a critical time of new partnerships and product launch. — BioSkryb has industry leading genome amplification technology that enables true comprehensive multi-omic analysis, at high resolution, in single cells. For more information, please visit: https://www.bioskryb.com/
BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis.
Raised $31,500,000.00 from Anzu Partners and Anzu Partners.
Board Observer
2021 - 2024
Business Development
2023 - 2023
Active portfolio company support is an important part of our investor mandate at Anzu Partners. I had the opportunity to work with our company Terapore to support business development. — Terapore is developing next-generation precise nanofiltration solutions for bioprocessing and beyond! For more information, please visit: https://www.terapore.com/
Director, Business Development
2018 - 2021
Zymergen is a science & material innovation company rethinking biology and reimagining the world. We partner with nature to create the products of tomorrow.
Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.
Raised $974,140,000.00 from SoftBank Vision Fund, DCVC, True Ventures, Baron Capital, Perceptive Advisors, Baillie Gifford and Employee Stock Option Fund.
Business Development Manager
2015 - 2017